Expanding at a CAGR of 6.5%, the global infection control market is projected to increase from a valuation of US$ 201.4 Bn in 2021 to US$ 396.4 Bn by 2032.
“The increasing adoption of infection control by hospitals and manufacturing organizations, and increasing government initiatives to control the outbreak of infections will help the global infection control market to generate great revenue in the projected period.”
The process of preventing or eliminating the spread of infections or harmful contaminates in healthcare settings is referred to as infection control. Infection control is the approach used to prevent the transmission of infectious disorders that are caused because of viruses, bacteria, and fungi. These microorganisms can cause several infections such as urinary tract, respiratory, skin, and ear infections.
The preventive measures in infection control include cleaning, respiratory hygiene, waste disposal, and disinfection. On the other hand, the controlling mode of transmission includes safe injection, ventilation of space, and hand hygiene. Besides this, the crucial infection control activities carried out in hospitals, laboratories, clinics, food manufacturing units, and the pharmaceutical sector are sterilization, cleaning, and disinfection of the surfaces, equipment, and objects.
| Attributes | Details |
|---|---|
| Infection Control Market Value in 2021 | US$ 201.4 Billion |
| Infection Control Market Value in 2032 | US$ 396.4 Billion |
| Infection Control Market CAGR (2022 to 2032) | 6.5% |
The major factors such as increasing infection outbreaks, growing number of surgeries, increasing prevalence of chronic disorders associated with the growing old age populace, and the budding medical device reprocessing industry are anticipated to propel the market growth for infection control. Additionally, the growing incidence of hospital-associated infections and surgical site infections is propelling the market growth. Infection control is utilized to reduce the risk of harmful infections, which is highly used in hospitals, clinics, laboratories and research institutes, and food and pharmaceutical manufacturing units. Thus, the increasing demand for infection control in these sectors is boosting the growth of the market.
Moreover, the growth in the outsourcing of sterilization facilities and the introduction of innovative sterilizing solutions are expected to contribute to the growth of the infection control market. Furthermore, to ensure a high degree of infection prevention, the government is taking a number of initiatives, which is attributed to show significant growth in the infection control market.
North America holds a larger market share in the infection control market followed by Europe, East Asia, South Asia, and other regions. The lucrative growth in North America is attributed due to the increasing adoption of disinfection and sterilization equipment, and rising concerns about disease prevention among the population.
The Asian regions are expected to be the rapidly growing regions owing to the COVID-19 outbreak, increasing focus of government on the healthcare sector, and growing prevalence of chronic illness. Latin America and the Middle East and Africa are estimated to show sustainable growth during the projected period.
Some of the key players operating in the infection control market are Nordion Inc., Johnson & Johnson Private Limited, BELIMED INC., Getinge AB., Medivators Inc., Kimberly-Clark Corporation, CISA Group, STERIS, Ecolab, and Advanced Sterilization Products.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 6.5% 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segment Covered |
|
| Region Covered |
|
| Key Countries Profiled |
|
| Key Players |
|
| Customization | Available Upon Request |
The global infection control market is anticipated to register a CAGR of 6.5% during the forecast period.
The infection control market is projected to be about US$ 396.4 Bn by the end of year 2032.
Explore Similar Insights
Infection Control Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
